Clinical Trial Update: 18F-NaF PET Imaging for Bone Scintigraphy [Phase 3]

View source ↗

Summary

Phase 3 trial update on 18F-NaF PET imaging for bone scintigraphy in patients with bone metastases from breast or prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Breast Cancer
• Prostate Cancer

Drugs mentioned

• 18F-NaF (sodium fluoride labeled with fluorine-18)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Bone Metastases From Breast or Prostate Cancer | Phase 3 | Status: COMPLETED